Published in Medical Letter on the CDC and FDA, November 7th, 2004
The satellite symposium was held in conjunction with the American Neurological Association's 129th annual meeting in Toronto, Ontario.
HD is a debilitating central nervous system (CNS) disorder marked by incessant involuntary movements for which there is no approved therapy in the United States. Tetrabenazine is a dopamine depletor currently on the market in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.